TUXUMDONLAR POLIKISTOZ SINDROMIDA METABOLIK SINDROMNI BARVAQT ANIQLASH VA SKRININGNI OPTIMALLASHTIRISH: ZAMONAVIY DIAGNOSTIK YONDASHUVLAR
Abstract
Annotatsiya
Maqsad: Polikistoz tuxumdon sindromli (TPS) ayollarda metabolik sindromni
(MS) barvaqt aniqlash va skrining bo‘yicha zamonaviy diagnostik mezonlar,
laboratoriya biomarkerlari va integratsiyalashgan yondashuvlarni tahlil qilish,
shuningdek klinik amaliyotga mos optimallashtirilgan diagnostika algoritmini taklif
etish.
References
Foydalanilgan adabiyotlar:
1. Amisi CA. Markers of insulin resistance in Polycystic ovary syndrome women: An
update. World J Diabetes. 2022;13(3):129-149. doi:10.4239/wjd.v13.i3.129 ([1]
[10])
2. Prosperi S, Chiarelli F. Insulin resistance, metabolic syndrome and polycystic
ovaries: an intriguing conundrum. Front Endocrinol (Lausanne). 2025;16:1669716.
Published 2025 Oct 1. doi:10.3389/fendo.2025.1669716 ([2] [4] [7] [8] [9] [11])
3. Zhao X, Feng X, Zhao X, et al. How to Screen and Prevent Metabolic Syndrome in
Patients of PCOS Early: Implications From Metabolomics. Front Endocrinol
(Lausanne). 2021;12:659268. Published 2021 Jun 2.
doi:10.3389/fendo.2021.659268 ([3])
4. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic
ovary syndrome: an Endocrine Society clinical practice guideline. Am Fam
Physician. 2016;94(2):106-113.
https://www.aafp.org/pubs/afp/issues/2016/0715/p106.html ([5] [6])
